Ignite Creation Date:
2025-12-24 @ 12:50 PM
Ignite Modification Date:
2025-12-25 @ 12:15 PM
Study NCT ID:
NCT04507061
Status:
COMPLETED
Last Update Posted:
2023-04-04
First Post:
2020-08-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels.
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-05
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-06
First Submit QC Date:
None
Study First Post Date:
2020-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-31
Last Update Post Date:
2023-04-04
Last Update Post Date Type:
ACTUAL